National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1400434

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1400434
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-05-31
Onset:2021-06-01
Submitted:0000-00-00
Entered:2021-06-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EX7823 / 2 - / OT

Administered by: Other      Purchased by: ??
Symptoms: Angina pectoris, Fatigue, Headache, Contusion

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': BGPFIZER INC2021664186

Write-up: heart pain; large bruise at the application site; general fatigue; headaches; This is a spontaneous report from a contactable consumer. This is second case of two cases for same patient, same product, difference adverse events and dose. A 42-years-old female patient received second dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EX7823, Expiration date was not reported), via intramuscular on 31May2021 as 2nd dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took (COMIRNATY Solution for injection) for covid-19 immunisation. On 01Jun2021 the patient experienced large bruise at the application site, general fatigue, heart pain, headaches. Three days before the vaccine and 4 days after the patient was taking an antihistamine. Patient did not received any treatment. On an unspecified date in 2021, the outcome of the events was recovered without treatment. Follow-up attempt completed. No expected further information. Amendment: This follow-up report is being submitted to amend previously reported Information: Amended the reported "heart pain" to LLT Cardiac Pain (PT Angina Pectoris) and upgraded the event to serious as this term is included the MedDRA Critical Preferred Terms List.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1400434&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166